Yuan-Sheng Zang Selected Research

Yuan-Sheng Zang Research Topics

Disease

22	Neoplasms (Cancer) 01/2023 - 01/2008
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 03/2013
7	Adenocarcinoma of Lung 11/2023 - 01/2008
7	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 01/2019
7	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2008
4	Neoplasm Metastasis (Metastasis) 03/2020 - 04/2015
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2018
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2021
2	Adenocarcinoma 01/2021 - 01/2008
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2019
1	Disease Progression 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 05/2021
1	Ovarian Epithelial Carcinoma 05/2021
1	Precocious Puberty 01/2021
1	Medullary Carcinoma 01/2021
1	Carcinogenesis 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Hand-Foot Syndrome 08/2020
1	Margins of Excision 01/2020
1	Anemia 01/2020
1	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Nasopharyngeal Carcinoma 12/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Microsatellite Instability 01/2019
1	Nausea 01/2018
1	Dizziness (Lightheadedness) 01/2018
1	Meningeal Carcinomatosis 01/2018
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 05/2016
1	Intestinal Obstruction (Obstruction, Intestinal) 05/2016
1	Carcinoma (Carcinomatosis) 04/2015
1	Malignant Pleural Effusion 04/2015
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2014
1	Infections 01/2014
1	Human Influenza (Influenza) 01/2014

Drug/Important Bio-Agent (IBA)

7	Immune Checkpoint InhibitorsIBA 01/2023 - 07/2018
6	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2019
4	ErbB Receptors (EGF Receptor)IBA 11/2023 - 11/2019
3	Tyrosine Kinase InhibitorsIBA 11/2023 - 01/2021
3	VemurafenibIBA 01/2022 - 01/2019
3	Cetuximab (Erbitux)FDA Link 01/2022 - 01/2019
2	osimertinibIBA 11/2023 - 01/2018
2	Angiogenesis InhibitorsIBA 01/2023 - 12/2022
2	Long Noncoding RNAIBA 10/2022 - 05/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 01/2019
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 01/2019
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2018
2	CrizotinibIBA 01/2021 - 01/2019
2	alectinibIBA 01/2021 - 01/2021
2	Capecitabine (Xeloda)FDA Link 01/2019 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015 - 01/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2015 - 01/2014
2	Arsenic Trioxide (Trisenox)FDA Link 04/2015 - 01/2014
2	CytokinesIBA 01/2014 - 06/2012
1	Gefitinib (Iressa)FDA Link 11/2023
1	anlotinibIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 10/2022
1	Antisense RNA (Anti-Sense RNA)IBA 10/2022
1	ChromatinIBA 01/2022
1	Leucovorin (Folinic Acid)FDA Link 01/2022
1	UbiquitinIBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 07/2021
1	lorlatinibIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Competitive Endogenous RNAIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	human ERBB2 proteinIBA 01/2021
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2021
1	NucleotidesIBA 01/2021
1	Urethane (Ethyl Carbamate)IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Proton Pump InhibitorsIBA 01/2021
1	Formaldehyde (Formol)FDA Link 07/2020
1	ParaffinIBA 07/2020
1	pyrotinibIBA 01/2020
1	palbociclibIBA 12/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019
1	Adenosine Monophosphate (AMP)IBA 01/2019
1	AfatinibIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Lapatinib (GW572016)FDA Link 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2018
1	130-nm albumin-bound paclitaxelIBA 05/2016
1	HLA-B Antigens (HLA-B)IBA 10/2014
1	InterleukinsIBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Interleukin-33IBA 01/2014
1	Interleukin-17 (Interleukin 17)IBA 01/2014
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2014
1	EnzymesIBA 01/2014
1	ImmunosorbentsIBA 01/2014

Therapy/Procedure

13	Therapeutics 04/2024 - 01/2008
10	Drug Therapy (Chemotherapy) 01/2022 - 01/2008
8	Immunotherapy 04/2024 - 07/2018
3	Radiotherapy 03/2021 - 01/2018
1	Aftercare (After-Treatment) 11/2023
1	Treatment Delay 12/2022
1	Adjuvant Chemotherapy 01/2019